AU2007205825B2 - Compositions and methods for preventing or treating feline chronic kidney disease - Google Patents
Compositions and methods for preventing or treating feline chronic kidney disease Download PDFInfo
- Publication number
- AU2007205825B2 AU2007205825B2 AU2007205825A AU2007205825A AU2007205825B2 AU 2007205825 B2 AU2007205825 B2 AU 2007205825B2 AU 2007205825 A AU2007205825 A AU 2007205825A AU 2007205825 A AU2007205825 A AU 2007205825A AU 2007205825 B2 AU2007205825 B2 AU 2007205825B2
- Authority
- AU
- Australia
- Prior art keywords
- composition
- protein
- feline
- ckd
- dry matter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000000203 mixture Substances 0.000 title claims description 308
- 241000282324 Felis Species 0.000 title claims description 241
- 208000020832 chronic kidney disease Diseases 0.000 title claims description 201
- 238000000034 method Methods 0.000 title claims description 63
- 108090000623 proteins and genes Proteins 0.000 claims description 207
- 102000004169 proteins and genes Human genes 0.000 claims description 207
- 108010082495 Dietary Plant Proteins Proteins 0.000 claims description 84
- 235000013305 food Nutrition 0.000 claims description 57
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 claims description 56
- 239000003795 chemical substances by application Substances 0.000 claims description 51
- 229910052698 phosphorus Inorganic materials 0.000 claims description 46
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 45
- 239000011574 phosphorus Substances 0.000 claims description 45
- 239000004615 ingredient Substances 0.000 claims description 38
- 229940109239 creatinine Drugs 0.000 claims description 28
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 27
- 229910052708 sodium Inorganic materials 0.000 claims description 27
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 26
- 239000011591 potassium Substances 0.000 claims description 26
- 229910052700 potassium Inorganic materials 0.000 claims description 26
- 239000011734 sodium Substances 0.000 claims description 26
- 210000002966 serum Anatomy 0.000 claims description 22
- 241001465754 Metazoa Species 0.000 claims description 18
- 239000003814 drug Substances 0.000 claims description 9
- 235000013311 vegetables Nutrition 0.000 claims description 8
- 230000000052 comparative effect Effects 0.000 claims 2
- 235000018102 proteins Nutrition 0.000 description 191
- 241000282326 Felis catus Species 0.000 description 45
- 150000001875 compounds Chemical class 0.000 description 9
- 239000012141 concentrate Substances 0.000 description 9
- 210000003734 kidney Anatomy 0.000 description 9
- 235000012054 meals Nutrition 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 230000003907 kidney function Effects 0.000 description 8
- 208000001647 Renal Insufficiency Diseases 0.000 description 7
- 230000008859 change Effects 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 201000006370 kidney failure Diseases 0.000 description 7
- 108010068370 Glutens Proteins 0.000 description 6
- 240000008042 Zea mays Species 0.000 description 6
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 6
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 6
- 235000005822 corn Nutrition 0.000 description 6
- 235000021312 gluten Nutrition 0.000 description 6
- 238000012423 maintenance Methods 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 235000019764 Soybean Meal Nutrition 0.000 description 5
- 208000017169 kidney disease Diseases 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 235000015277 pork Nutrition 0.000 description 5
- 239000004455 soybean meal Substances 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- 230000000007 visual effect Effects 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 208000037157 Azotemia Diseases 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 241000209140 Triticum Species 0.000 description 4
- 235000021307 Triticum Nutrition 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 108010070551 Meat Proteins Proteins 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000024924 glomerular filtration Effects 0.000 description 3
- 244000144977 poultry Species 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 102000003951 Erythropoietin Human genes 0.000 description 2
- 108090000394 Erythropoietin Proteins 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 108010084695 Pea Proteins Proteins 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- -1 e.g. Chemical compound 0.000 description 2
- 229940105423 erythropoietin Drugs 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 235000019702 pea protein Nutrition 0.000 description 2
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 235000021023 sodium intake Nutrition 0.000 description 2
- 229940071440 soy protein isolate Drugs 0.000 description 2
- 208000009852 uremia Diseases 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 239000005541 ACE inhibitor Substances 0.000 description 1
- XPCFTKFZXHTYIP-PMACEKPBSA-N Benazepril Chemical compound C([C@@H](C(=O)OCC)N[C@@H]1C(N(CC(O)=O)C2=CC=CC=C2CC1)=O)CC1=CC=CC=C1 XPCFTKFZXHTYIP-PMACEKPBSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- 241001466804 Carnivora Species 0.000 description 1
- 108010010256 Dietary Proteins Proteins 0.000 description 1
- 102000015781 Dietary Proteins Human genes 0.000 description 1
- 108010028690 Fish Proteins Proteins 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 208000008839 Kidney Neoplasms Diseases 0.000 description 1
- 208000005770 Secondary Hyperparathyroidism Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- YQEMAJLWJZJVOI-UHFFFAOYSA-N [P].[P].[P] Chemical compound [P].[P].[P] YQEMAJLWJZJVOI-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- ZPBWCRDSRKPIDG-UHFFFAOYSA-N amlodipine benzenesulfonate Chemical compound OS(=O)(=O)C1=CC=CC=C1.CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1Cl ZPBWCRDSRKPIDG-UHFFFAOYSA-N 0.000 description 1
- 229960004005 amlodipine besylate Drugs 0.000 description 1
- 239000003263 anabolic agent Substances 0.000 description 1
- 229940070021 anabolic steroids Drugs 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
- 235000019728 animal nutrition Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 229940125683 antiemetic agent Drugs 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 229960004530 benazepril Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000000480 calcium channel blocker Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 1
- 238000009535 clinical urine test Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 238000011862 kidney biopsy Methods 0.000 description 1
- 229940063711 lasix Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 238000002559 palpation Methods 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 125000004437 phosphorous atom Chemical group 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 235000021075 protein intake Nutrition 0.000 description 1
- 238000002601 radiography Methods 0.000 description 1
- 235000009643 reducing diet Nutrition 0.000 description 1
- 229940080693 reglan Drugs 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 125000004436 sodium atom Chemical group 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 235000003563 vegetarian diet Nutrition 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/22—Compounds of alkali metals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/26—Compounds containing phosphorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Physiology (AREA)
- Biotechnology (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Botany (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2011201233A AU2011201233B2 (en) | 2006-01-19 | 2011-03-18 | Compositions and methods for preventing or treating feline chronic kidney disease |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76006806P | 2006-01-19 | 2006-01-19 | |
| US60/760,068 | 2006-01-19 | ||
| PCT/US2007/060773 WO2007084986A2 (en) | 2006-01-19 | 2007-01-19 | Compositions and methods for preventing or treating feline chronic kidney disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2011201233A Division AU2011201233B2 (en) | 2006-01-19 | 2011-03-18 | Compositions and methods for preventing or treating feline chronic kidney disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2007205825A1 AU2007205825A1 (en) | 2007-07-26 |
| AU2007205825B2 true AU2007205825B2 (en) | 2011-05-26 |
Family
ID=38163311
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2007205825A Ceased AU2007205825B2 (en) | 2006-01-19 | 2007-01-19 | Compositions and methods for preventing or treating feline chronic kidney disease |
| AU2011201233A Ceased AU2011201233B2 (en) | 2006-01-19 | 2011-03-18 | Compositions and methods for preventing or treating feline chronic kidney disease |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2011201233A Ceased AU2011201233B2 (en) | 2006-01-19 | 2011-03-18 | Compositions and methods for preventing or treating feline chronic kidney disease |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20090275505A1 (enExample) |
| EP (2) | EP1981354B1 (enExample) |
| JP (1) | JP2009523827A (enExample) |
| CN (1) | CN101374421A (enExample) |
| AU (2) | AU2007205825B2 (enExample) |
| BR (1) | BRPI0706679A2 (enExample) |
| CA (1) | CA2636039C (enExample) |
| RU (1) | RU2404684C2 (enExample) |
| WO (1) | WO2007084986A2 (enExample) |
| ZA (1) | ZA200805958B (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8501223B2 (en) | 2003-06-20 | 2013-08-06 | Hill's Pet Nutrition, Inc. | Methods for dietary management of cats to avoid hyperthyroidism |
| RU2432941C2 (ru) * | 2006-01-26 | 2011-11-10 | Хилл'С Пет Ньютришн, Инк. | Способы и композиции для лечения гипертиреоза у кошачьих |
| CA2650845C (en) * | 2006-05-12 | 2015-07-07 | Hill's Pet Nutrition, Inc. | Compositions and methods for preventing or treating chronic renal failure in felines with hyperthyroidism |
| EP2471378A1 (en) * | 2006-07-03 | 2012-07-04 | Hill's Pet Nutrition, Inc. | Compositions and methods for preventing or treating cardiovascular diseases in felines with hyperthyroidism |
| JP6154136B2 (ja) | 2009-12-29 | 2017-06-28 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | コンパニオン動物のためのピルベートを含む組成物、およびその使用法 |
| CN104837361A (zh) * | 2012-12-13 | 2015-08-12 | 尤妮佳股份有限公司 | 宠物食品 |
| FR3002735B1 (fr) | 2013-03-04 | 2015-07-03 | Virbac | Composition orale nutritionnelle et medicamenteuse a usage veterinaire |
| FR3002736B1 (fr) * | 2013-03-04 | 2015-06-26 | Virbac | Composition orale nutritionnelle et medicamenteuse a usage veterinaire |
| WO2014138304A1 (en) | 2013-03-08 | 2014-09-12 | Axiom Foods, Inc., | Rice protein supplements |
| US9820504B2 (en) | 2013-03-08 | 2017-11-21 | Axiom Foods, Inc. | Rice protein supplement and methods of use thereof |
| EP3065559B1 (en) * | 2013-11-05 | 2019-01-09 | Hill's Pet Nutrition, Inc. | Palatability enhancers for foods designed for dogs and cats with renal insufficiency |
| TW201701773A (zh) * | 2015-03-20 | 2017-01-16 | 明治股份有限公司 | 腎機能改善劑 |
| WO2018209131A1 (en) | 2017-05-12 | 2018-11-15 | Axiom Foods, Inc. | Rice products and systems and methods for making thereof |
| BR112021015145A2 (pt) * | 2019-02-01 | 2021-09-28 | Mars, Incorporated | Composição alimentar felina |
| CN110870512A (zh) * | 2019-04-10 | 2020-03-10 | 张璐 | 猫慢性肾脏疾病饮食配方 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6039952A (en) * | 1997-10-22 | 2000-03-21 | The Iams Company | Composition and method for improving clinical signs in animals with renal disease |
| US20050064016A1 (en) * | 2003-06-20 | 2005-03-24 | Wedekind Karen J. | Methods for dietary management of cats to avoid hyperthyroidism |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04210639A (ja) * | 1990-11-30 | 1992-07-31 | Dainippon Pharmaceut Co Ltd | 電解質含量を低減化した食物繊維 |
| JPH06197715A (ja) * | 1992-03-16 | 1994-07-19 | Kissei Pharmaceut Co Ltd | たんぱく質調整そば |
| JPH11243879A (ja) * | 1998-03-04 | 1999-09-14 | Honke Matsuura Shuzojo:Kk | 低リン米の製造方法およびそれによって得られる低リン、低タンパク、低カリウム米 |
| AU769669B2 (en) * | 1998-09-02 | 2004-01-29 | Heska Corporation | Method and composition to protect an obligate carnivore from a disease of abnormal carbohydrate metabolism |
| JP2002204668A (ja) * | 2001-01-11 | 2002-07-23 | Q P Corp | 栄養組成物 |
| JP2003334009A (ja) * | 2002-05-20 | 2003-11-25 | Kissei Pharmaceut Co Ltd | 成分調整餅様食品 |
| ATE497351T1 (de) * | 2003-06-20 | 2011-02-15 | Hills Pet Nutrition Inc | Verfahren für die schilddrüsenüberfunktion bei der katze sowie zusammensetzungen mit eingeschränktem jodgehalt |
| CA2650845C (en) * | 2006-05-12 | 2015-07-07 | Hill's Pet Nutrition, Inc. | Compositions and methods for preventing or treating chronic renal failure in felines with hyperthyroidism |
-
2007
- 2007-01-19 BR BRPI0706679-1A patent/BRPI0706679A2/pt not_active IP Right Cessation
- 2007-01-19 CA CA2636039A patent/CA2636039C/en not_active Expired - Fee Related
- 2007-01-19 WO PCT/US2007/060773 patent/WO2007084986A2/en not_active Ceased
- 2007-01-19 JP JP2008551549A patent/JP2009523827A/ja active Pending
- 2007-01-19 US US12/161,583 patent/US20090275505A1/en not_active Abandoned
- 2007-01-19 RU RU2008133986/13A patent/RU2404684C2/ru not_active IP Right Cessation
- 2007-01-19 CN CNA2007800032392A patent/CN101374421A/zh active Pending
- 2007-01-19 EP EP07717323.5A patent/EP1981354B1/en active Active
- 2007-01-19 EP EP12158853.7A patent/EP2462815B1/en active Active
- 2007-01-19 AU AU2007205825A patent/AU2007205825B2/en not_active Ceased
-
2008
- 2008-07-08 ZA ZA2008/05958A patent/ZA200805958B/en unknown
-
2011
- 2011-03-18 AU AU2011201233A patent/AU2011201233B2/en not_active Ceased
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6039952A (en) * | 1997-10-22 | 2000-03-21 | The Iams Company | Composition and method for improving clinical signs in animals with renal disease |
| US20050064016A1 (en) * | 2003-06-20 | 2005-03-24 | Wedekind Karen J. | Methods for dietary management of cats to avoid hyperthyroidism |
Non-Patent Citations (6)
| Title |
|---|
| ANONYMOUS: "Ami Products-Ingredients" Internet Article, [Online] 24 June 2004 Retrieved from the internet: URL: http://web.archive.org/web/20030624115116/http://ami.aminews.net/en_ingredienti.html * |
| ANONYMOUS: "Benevo Vegetarian Cat Food" Internet Article, [Online] 10 September 2005 Retd from internet: http://web.archive.org/web/20050910051942/http://www.veggiepets.com/acatalog/benevo_vegetarian_cat_food.html * |
| BROOKS, W.C. "Kidney Failure: Where to Begin" Internet Article, [Online] 1 January 2001, Retrieved from the internet: URL:http:// www.veterinarypartner.com/Content.plx?P=A&S=0&C=0 * |
| BROWN, S.A. et al., "Pathophysiology and Management of Progressive Renal Disease", The Veterinary Journal, 1997, Volume 154, Pages 93-109. * |
| HUGHES, K.L. et al., "Diet and Lifestyle Variables as Risk Factors for Chronic Renal Failure in Pet Cats", Preventive Veterinary Medicine, 2002, Volume 55, Pages 1-15 * |
| POLZIN, D.J. et al., "Dietary Management of Feline Chronic Renal Failure: Where Are We Now? In What Direction Are We Headed?" Journal of Feline Medicine and Surgery, 2000, Volume 2, pages 75-82 * |
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200805958B (en) | 2014-09-25 |
| AU2011201233B2 (en) | 2011-08-04 |
| WO2007084986A3 (en) | 2007-11-22 |
| JP2009523827A (ja) | 2009-06-25 |
| EP2462815A1 (en) | 2012-06-13 |
| RU2404684C2 (ru) | 2010-11-27 |
| CN101374421A (zh) | 2009-02-25 |
| WO2007084986A2 (en) | 2007-07-26 |
| AU2007205825A1 (en) | 2007-07-26 |
| EP2462815B1 (en) | 2020-11-11 |
| BRPI0706679A2 (pt) | 2011-04-05 |
| RU2008133986A (ru) | 2010-02-27 |
| EP1981354A2 (en) | 2008-10-22 |
| AU2011201233A1 (en) | 2011-04-07 |
| CA2636039A1 (en) | 2007-07-26 |
| EP1981354B1 (en) | 2017-11-15 |
| CA2636039C (en) | 2013-03-19 |
| US20090275505A1 (en) | 2009-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2007205825B2 (en) | Compositions and methods for preventing or treating feline chronic kidney disease | |
| EP2037756B1 (en) | Compositions and methods for preventing or treating chronic renal failure in felines with hyperthyroidism | |
| DK2666366T3 (en) | METHODS AND COMPOSITIONS FOR TREATING FELIN HYPERTHYROIDISM | |
| EP1838166B1 (en) | Compositions and methods for improving kidney function | |
| AU2006263651B2 (en) | Methods and compositions for the prevention and treatment of kidney disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |